Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice.
Open Access
- 26 April 1994
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 91 (9), 3764-3768
- https://doi.org/10.1073/pnas.91.9.3764
Abstract
During hepatitis B virus (HBV) infection, distinct host-virus interactions may establish the patterns of viral clearance and persistence and the extent of virus-associated pathology. It is generally thought that HBV-specific class I-restricted cytotoxic T lymphocytes (CTLs) play a critical role in this process by destroying infected hepatocytes. This cytopathic mechanism, however, could be lethal if most of the hepatocytes are infected. In the current study, we demonstrate that class I-restricted HBV-specific CTLs profoundly suppress hepatocellular HBV gene expression in HBV transgenic mice by a noncytolytic process, the strength of which greatly exceeds the cytopathic effect of the CTLs in magnitude and duration. We also show that the regulatory effect of the CTLs is initially mediated by interferon gamma and tumor necrosis factor alpha, is delayed in onset, and becomes independent of these cytokines shortly after it begins. The data indicate that the anti-viral CTL response activates a complex regulatory cascade that inhibits hepatocellular HBV gene expression without killing the cell. The extent to which this mechanism contributes to viral clearance or viral persistence during HBV infection remains to be determined.Keywords
This publication has 15 references indexed in Scilit:
- Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo.The Journal of Immunology, 1994
- Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic miceJournal of Virology, 1992
- Generation of monoclonal antibodies to murine IL-1 beta and demonstration of IL-1 in vivo.The Journal of Immunology, 1991
- Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.The Journal of Immunology, 1990
- Immunobiology and Pathogenesis of Hepatocellular Injury in Hepatitis B Virus Transgenic MiceScience, 1990
- Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic miceCell, 1989
- Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.The Journal of Immunology, 1989
- Monoclonal antibodies to murine IL-1 alpha. Production, characterization, and inhibition of membrane-associated IL-1 activity.The Journal of Immunology, 1988
- Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform ExtractionAnalytical Biochemistry, 1987
- Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.The Journal of Immunology, 1985